• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童新型冠状病毒病(COVID-19)。

Novel coronavirus disease (COVID-19) in children.

机构信息

Department of Pediatric Infectious Disease, Faculty of Medicine, Gazi University, Ankara, Turkey

Department of Pediatric Infectious Disease, Ankara City Hospital, Ankara, Turkey

出版信息

Turk J Med Sci. 2020 Apr 21;50(SI-1):592-603. doi: 10.3906/sag-2004-174.

DOI:10.3906/sag-2004-174
PMID:32304191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7195991/
Abstract

Coronavirus disease (COVID-19) was firstly reported at the end of 2019. The disease rapidly spread all around the world in a few months and was declared a worldwide pandemic by WHO in March 2020. By April 9, there were 1,436,198 confirmed COVID-19 cases in the world, nearly with 6% mortality rate. This novel infectious disease causes respiratory tract illness that may generally occur as mild upper respiratory tract disease or pneumonia. In older patients and/or patients with underlying conditions, it may result in acute respiratory distress syndrome, multi organ failure and even death. According to the current literature, children account approximately for 1%–5% of diagnosed COVID-19 cases. Generally, COVID-19 seems to be a less severe disease for children than adults. Approximately 90% of pediatric patients are diagnosed as asymptomatic, mild, or moderate disease. However, up to 6.7% of cases may be severe. Severe illness is generally seen in patients smaller than 1 year of age and patients who have underlying disesases. The epidemiological and clinical patterns of COVID-19 and treatment approaches in pediatric patients still remain unclear although many pediatric reports are published. This review aims to summarize the current epidemics, clinical presentations, diagnosis, and treatment of COVID-19 in pediatric patients.

摘要

冠状病毒病(COVID-19)于 2019 年底首次报告。该疾病在短短几个月内迅速在全球范围内传播,并于 2020 年 3 月被世界卫生组织宣布为全球大流行。截至 4 月 9 日,全球已确诊 COVID-19 病例 1436198 例,死亡率接近 6%。这种新型传染病会引起呼吸道疾病,通常表现为轻度上呼吸道疾病或肺炎。在老年患者和/或有基础疾病的患者中,可能导致急性呼吸窘迫综合征、多器官衰竭甚至死亡。根据目前的文献,儿童约占确诊 COVID-19 病例的 1%-5%。一般来说,COVID-19 对儿童的严重程度似乎低于成人。大约 90%的儿科患者被诊断为无症状、轻度或中度疾病。然而,高达 6.7%的病例可能是严重的。严重疾病一般见于 1 岁以下的患者和有基础疾病的患者。尽管发表了许多儿科报告,但 COVID-19 在儿科患者中的流行病学和临床模式以及治疗方法仍不清楚。本综述旨在总结 COVID-19 在儿科患者中的当前流行情况、临床表现、诊断和治疗。

相似文献

1
Novel coronavirus disease (COVID-19) in children.儿童新型冠状病毒病(COVID-19)。
Turk J Med Sci. 2020 Apr 21;50(SI-1):592-603. doi: 10.3906/sag-2004-174.
2
COVID-19 - What does a paediatrician need to know?COVID-19 - 儿科医生需要了解什么?
Paediatr Respir Rev. 2020 Sep;35:3-8. doi: 10.1016/j.prrv.2020.05.001. Epub 2020 May 11.
3
COVID-19 in Children: Clinical Approach and Management.儿童 COVID-19:临床方法与管理。
Indian J Pediatr. 2020 Jun;87(6):433-442. doi: 10.1007/s12098-020-03292-1. Epub 2020 Apr 27.
4
SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染导致新型冠状病毒肺炎(COVID-19)患者出现腹泻作为首发症状。
Gut. 2020 Jun;69(6):1143-1144. doi: 10.1136/gutjnl-2020-320891. Epub 2020 Mar 5.
5
SARS-COV-2 infection in children and newborns: a systematic review.儿童和新生儿中的 SARS-CoV-2 感染:系统评价。
Eur J Pediatr. 2020 Jul;179(7):1029-1046. doi: 10.1007/s00431-020-03684-7. Epub 2020 May 18.
6
A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children.儿科传染病视角下的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 年新型冠状病毒病(COVID-19)在儿童中的表现。
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):596-608. doi: 10.1093/jpids/piaa099.
7
Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks.儿童 COVID-19 感染的特征:来自两个意大利儿科研究网络的早期发现。
Eur J Pediatr. 2020 Aug;179(8):1315-1323. doi: 10.1007/s00431-020-03683-8. Epub 2020 Jun 3.
8
Our recommendations for acute management of COVID-19.我们对新型冠状病毒肺炎急性处理的建议。
Crit Care. 2020 May 8;24(1):207. doi: 10.1186/s13054-020-02930-6.
9
COVID-19 diagnosis and management: a comprehensive review.COVID-19 的诊断与管理:全面综述。
J Intern Med. 2020 Aug;288(2):192-206. doi: 10.1111/joim.13091. Epub 2020 May 13.
10
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.

引用本文的文献

1
Risk Factors and Clinical Features of Deterioration in 739 COVID-19 Affected Children Aged Under 14 Years in Zhuhai, China: A Multicenter, Retrospective Study.中国珠海739例14岁以下新冠病毒感染儿童病情恶化的危险因素及临床特征:一项多中心回顾性研究
Pediatr Discov. 2025 May 19;3(2):e70001. doi: 10.1002/pdi3.70001. eCollection 2025 Jun.
2
Agenda for COVID-19 and long COVID research priorities in Brazil: results of wide consultation and Delphi consensus, 2022-2023.巴西2019冠状病毒病及新冠长期症状研究重点议程:2022 - 2023年广泛咨询与德尔菲共识结果
Epidemiol Serv Saude. 2025 Jun 20;34:e20240623. doi: 10.1590/S2237-96222025v34e20240623.en. eCollection 2025.
3
Association Between Single-Nucleotide Polymorphisms in (), , and Genes with Severe Symptoms in Children Presenting COVID-19.新型冠状病毒肺炎患儿中()、、和基因单核苷酸多态性与严重症状之间的关联。 (注:原文括号处内容缺失)
Viruses. 2024 Dec 30;17(1):35. doi: 10.3390/v17010035.
4
Retrospective Analysis of Clinical Characteristics and Disease Outcomes in Children and Adolescents Hospitalized Due to COVID-19 Infection in Tunisia.突尼斯因 COVID-19 感染住院的儿童和青少年的临床特征和疾病结局的回顾性分析。
Viruses. 2024 May 14;16(5):779. doi: 10.3390/v16050779.
5
Spectrum of COVID-19 induced liver injury: A review report.新型冠状病毒肺炎所致肝损伤的研究现状:一篇综述报告
World J Hepatol. 2024 Apr 27;16(4):517-536. doi: 10.4254/wjh.v16.i4.517.
6
Combined Hyperglycemic Hyperosmolar Syndrome and Diabetic Ketoacidosis Associated with COVID-19 in a Pediatric Patient.一名儿科患者中与新冠病毒感染相关的高血糖高渗综合征合并糖尿病酮症酸中毒
Case Rep Crit Care. 2021 Nov 27;2021:6429710. doi: 10.1155/2021/6429710. eCollection 2021.
7
Management of neonates with maternal prenatal coronavirus infection and influencing factors.新生儿产妇产前冠状病毒感染的管理及影响因素。
Pediatr Res. 2024 Jan;95(2):436-444. doi: 10.1038/s41390-023-02855-0. Epub 2023 Oct 19.
8
"Multisystem Inflammatory Syndrome in Children" (MIS-C) after COVID-19 Infection in the Metropolitan Area of Nuremberg-Erlangen, Germany-Expectations and Results of a Two-Year Period.德国纽伦堡 - 埃尔朗根都会区新冠病毒感染后儿童多系统炎症综合征(MIS-C):两年期间的预期与结果
Children (Basel). 2023 Aug 9;10(8):1363. doi: 10.3390/children10081363.
9
Transmission and Profile of COVID-19 in Children in North Sumatera, Indonesia.印度尼西亚北苏门答腊省儿童的 COVID-19 传播和特征。
Arch Iran Med. 2022 Nov 1;25(11):737-741. doi: 10.34172/aim.2022.116.
10
Comparative study of pandemics and their impact on children and adolescents: COVID-19 and Spanish Flu.大流行及其对儿童和青少年影响的比较研究:新冠疫情与西班牙流感。
Infez Med. 2023 Jun 1;31(2):131-139. doi: 10.53854/liim-3102-1. eCollection 2023.

本文引用的文献

1
Molecular immune pathogenesis and diagnosis of COVID-19.新型冠状病毒肺炎的分子免疫发病机制与诊断
J Pharm Anal. 2020 Apr;10(2):102-108. doi: 10.1016/j.jpha.2020.03.001. Epub 2020 Mar 5.
2
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病(COVID-19):综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
3
Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019.儿童 2019 冠状病毒病患者粪便中病毒持续排出。
J Microbiol Immunol Infect. 2020 Jun;53(3):473-480. doi: 10.1016/j.jmii.2020.03.021. Epub 2020 Mar 28.
4
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
5
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.大剂量静脉注射免疫球蛋白作为新型冠状病毒肺炎病情恶化患者的一种治疗选择
Open Forum Infect Dis. 2020 Mar 21;7(3):ofaa102. doi: 10.1093/ofid/ofaa102. eCollection 2020 Mar.
6
Deployment of convalescent plasma for the prevention and treatment of COVID-19.恢复期血浆在 COVID-19 预防和治疗中的应用。
J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745.
7
Epidemiology and clinical features of coronavirus disease 2019 in children.2019年冠状病毒病在儿童中的流行病学及临床特征
Clin Exp Pediatr. 2020 Apr;63(4):125-132. doi: 10.3345/cep.2020.00535. Epub 2020 Apr 6.
8
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?体外膜肺氧合(ECMO):在治疗严重 COVID-19 中是否有作用?
Int J Infect Dis. 2020 May;94:78-80. doi: 10.1016/j.ijid.2020.03.058. Epub 2020 Apr 3.
9
COVID-19 in children and altered inflammatory responses.儿童新冠病毒感染与炎症反应改变
Pediatr Res. 2020 Sep;88(3):340-341. doi: 10.1038/s41390-020-0881-y. Epub 2020 Apr 3.
10
Breastfeeding and coronavirus disease-2019: Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies.母乳喂养与 2019 年冠状病毒病:意大利新生儿学会的临时建议,得到欧洲新生儿与围产医学会联盟的认可。
Matern Child Nutr. 2020 Jul;16(3):e13010. doi: 10.1111/mcn.13010. Epub 2020 Apr 26.